OBJECTIVE -To characterize glucose levels during daily living using continuous glucose monitors (CGMs) in nondiabetic individuals.
C ontinuous glucose monitors (CGMs), which measure interstitial glucose concentrations, are increasingly being used in clinical practice and in clinical research in patients with diabetes. However, the variation in glucose levels measured by CGM in healthy, nondiabetic individuals during daily living has not been extensively studied. The aim of this study was to characterize CGM glucose patterns in healthy, nondiabetic individuals.
RESEARCH DESIGN AND METHODS -
The study was conducted at 10 adult and pediatric diabetes centers, after approval by their institutional review boards. Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an individual with type 1 diabetes. Subjects provided written informed consent and children gave assent to study participation. Inclusion criteria were: age Ն8 years old; BMI 10th to 90th percentile for age and sex for subjects Ͻ18 years old (based on 2000 Centers for Disease Control and Prevention (CDC) nomogram) and Ͻ28 kg/m 2 for subjects Ն18 years old; no significant chronic illness or taking of any medications that might affect glucose metabolism; A1C Յ6.0%; fasting blood glucose 70 to 99 mg/dl; 2-h oral glucose tolerance test (OGTT) level Յ140 mg/dl; and negative anti-GAD, anti-IA2, and anti-insulin antibodies. Of 148 subjects screened for the study, 39 were excluded because of low fasting glucose (n ϭ 3), elevated fasting glucose (n ϭ 16), elevated 2-h glucose (n ϭ 5), positive antibodies (n ϭ 8), ineligible BMI (n ϭ 3), ineligible A1C (n ϭ 1), or insufficient sensor data (n ϭ 3).
Subjects used either a Guardian Clinical (n ϭ 38; Medtronic MiniMed, Northridge, CA) for 3 days, a FreeStyle Navigator (n ϭ 36; Abbott Diabetes Care, Alameda, CA) for 5 days, or a DexCom SEVEN (n ϭ 35, DexCom, San Diego, CA) for 7 days. Subjects were instructed on calibration of the devices using a home blood glucose meter. Results using the DexCom sensor were not included in the analysis because of the frequency of missing data because of overnight dropout of sensor function, and because there was a disproportionate number of low and high glucose values compared with the other sensors, which seemed unlikely to represent true extreme values in these nondiabetic individuals. Notably, the current commercially available DexCom device contains newer software than the devices used in our study. The discrepancies between the DexCom results and the other two devices is shown in supplemental Computed statistics included are mean Ϯ SD for the glucose and medians for the percentage of sensor glucose values in glucose ranges and glucose variability measures overall and in four agegroups: 8 to Ͻ15, 15 to Ͻ25, 25 to Ͻ45, and Ն45 years. The association of A1C,
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E m e r g i n g T r e a t m e n t s a n d T e c h n o l o g i e s fasting blood glucose, and 2-h postprandial blood glucose with age was assessed using least-squares regression models. The associations of mean sensor glucose and glucose variability measures with age were assessed using least-squares regression models adjusting for device type. The repeated-measures regression models were used to compare mean glucose and glucose variability measures during daytime versus nighttime, adjusting for device type and age. Rank scores were transformed to have a normal distribution, using van der Waerden scores for glucose variability measures because of the skewed distributions. Regression models of glucose variability measures were adjusted for mean glucose as a covariate.
RESULTS -The 74 subjects ranged in age from 9 to 65 years old. Of them, 51 (69%) were female; 55 (74%) were non-Hispanic, Caucasian; 13 (18%) were Hispanic; 1 (1%) was African American; and 5 (7%) were other race/ethnicities. Mean A1C (Ϯ SD) was 5.3 Ϯ 0.3% (range 4.7-6.0%), fasting glucose was 86 Ϯ 8 mg/dl, and 2-h post-OGTT was 96 Ϯ 22 mg/dl; none of which varied meaningfully by age. Median BMI percentile was 82nd (interquartile range 62nd to 91st) for subjects Ͻ18 years old (n ϭ 26) and median BMI was 24.9 kg/m 2 (23.3, 26.3) for those Ն18 years old (n ϭ 48). CGM glucose values were obtained for a mean of 84 Ϯ 21 h per subject. As shown in Table 1 , the mean sensor glucose concentration was slightly higher during the day (6:00 A.M. to midnight) than during the night (midnight to 6:00 A.M., P Ͻ 0.001 comparing day and night). There was a slight association of lower age and higher mean glucose level (P ϭ 0.009), which was seen both during the day (P ϭ 0.04) and overnight (P Ͻ 0.001) ( Table 1 ; supplemental Figs. A-1 and A-2). Hourly means ranged from 92 mg/dl from 5:00 to 6:00 A.M. to 103 mg/dl from 8:00 to 10:00 P.M. (supplemental figure A-2) . The median percentage of sensor values between 71 and 120 mg/dl was 91%, 0.2% of values being Յ60 mg/dl and 0.4% Ͼ140 mg/dl; no subjects had 100% of values between 71 and 120 mg/dl (Table 1; supplemental Tables A-2 and A-3). Except for a slight tendency for a higher rate of change in younger subjects (P ϭ 0.04), other measures of glucose variability were not influenced by age (Table 1) . Glucose variability was lower at night than during the day (P Ͻ 0.001; Table 1 ). Results were similar comparing the Navigator and Guardian Clinical CGM devices (mean glucose 98 Ϯ 11 and 98 Ϯ 9 mg/dl, respectively).
CONCLUSIONS -In this study we have described sensor glucose profiles using the Medtronic and Abbott Diabetes CGM systems in healthy, anti-␤-cell antibody-negative subjects across the spectrum of pediatric and adult age ranges. Our mean sensor data were similar to those reported in healthy Chinese subjects using Medtronic's Continuous Glucose Monitoring System (1) . However, in that study, sensor values increased with advancing age, contrary to our data, and only subjects Ͼ20 years old were included.
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